This topic contains a solution. Click here to go to the answer

Author Question: A majority of funding for wildlife conservation comes from _____ hunter-generated dollars. a. ... (Read 101 times)

pane00

  • Hero Member
  • *****
  • Posts: 579
A majority of funding for wildlife conservation comes from _____ hunter-generated dollars.
 
  a. game and nongame
  b. renewable
  c. recreational
  d. market

Question 2

Which of the following statements regarding tarantula behavior is true?
 
  a. Most species live in trees.
  b. They are crepuscular.
  c. Only females can inject venom.
  d. They are most active during the day.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

essyface1

  • Sr. Member
  • ****
  • Posts: 347
Answer to Question 1

a

Answer to Question 2

B



pane00

  • Hero Member
  • *****
  • Posts: 579
Both answers were spot on, thank you once again



essyface1

  • Sr. Member
  • ****
  • Posts: 347

 

Did you know?

Approximately 70% of expectant mothers report experiencing some symptoms of morning sickness during the first trimester of pregnancy.

Did you know?

Barbituric acid, the base material of barbiturates, was first synthesized in 1863 by Adolph von Bayer. His company later went on to synthesize aspirin for the first time, and Bayer aspirin is still a popular brand today.

Did you know?

In 2010, opiate painkllers, such as morphine, OxyContin®, and Vicodin®, were tied to almost 60% of drug overdose deaths.

Did you know?

Signs and symptoms that may signify an eye tumor include general blurred vision, bulging eye(s), double vision, a sensation of a foreign body in the eye(s), iris defects, limited ability to move the eyelid(s), limited ability to move the eye(s), pain or discomfort in or around the eyes or eyelids, red or pink eyes, white or cloud spots on the eye(s), colored spots on the eyelid(s), swelling around the eyes, swollen eyelid(s), and general vision loss.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library